The world of celiac disease research changes and evolves each and every day. Beyond Celiac keeps the community up-to-date on research in many ways, including our Research News Feed and the Research Opt-In.
A new study that analyzed the activity of more than 10,000 genes found that a drug being investigated to treat celiac disease prevented intestinal damage caused by gluten.
Obesity was more common in those with celiac disease compared to those without celiac disease, analysis of a large national database of health information found.
Increased amounts of gluten in a gluten challenge for those on a gluten-free diet may be needed for accurate celiac disease blood tests done as part of diagnosis.
More than half of children with celiac disease did not get recommended blood test follow-ups in a study that used artificial intelligence to scan electronic health records.
View our interactive Drug Development Pipelineto see the current status of celiac disease drugs that are currently in development
Potential Celiac Disease Vaccines
A potential celiac disease vaccine could one day be a reality. Whenever new information is available we update our Research News and our Celiac Disease Vaccine page.
Celiac Disease Clinical Trials
Researchers around the world are working to develop new treatments for celiac disease. As a person affected by celiac disease, you can play an important role in advancing research by participating inclinical trials. View our Clinical Trials Infographic to learn how clinical trials tie into to drug development process.
Additionally, Beyond Celiac has been directly involved with assisting a number of clinical studies in all phases. With the largest celiac disease social community, a robust email and research database and a website that receives over 2 million visits a year, we are uniquely qualified to help your clinical trial recruit qualified candidates. Learn about our patient recruitment offerings.
Our Chief Scientific Officers lead the development and implementation of a transformational patient-centered research agenda focused on accelerating solutions toward new pharmaceutical treatments and a cure for celiac disease.
Our Chief Scientist and Strategy Officer develops our research and funding priorities to impact patients in areas including clinical decision-making about disease management, treatment, and eventually a cure.